• Search

Discovery Stems From Here     

Find your tools for building human cell-based models & screening assays

Welcome to Axol Bioscience


We provide highly validated human iPSC-derived cells and primary cells from healthy donors and patients of specific disease backgrounds, together with optimized media and growth supplements. Axol aims to develop the best human cell biology research tools to advance medical research and drug discovery. Combining our passion for science with quality, innovation and customer service, we deliver robust and reliable products that our customers need to advance their research faster.

Latest News

  • Axol Bioscience raises £3.2 million GBP (c. $4.2 million USD)

     Extension of previous funding round brings total raised to £7 million GBP (circa $9.2 million USD) with investment from Calculus Capital, Par Equity, and Scottish Enterprise. Funding will support continued development of Axol’s human iPS cell lines and reagents, and expansion of its commercial team


  • High-Throughput Human Model of Alzheimer’s Disease in a Dish

    In a recent study published in Nature Communications, researchers from Genentech and the University of California, San Francisco have created a human cellular model of Alzheimer’s Disease (AD) in a dish.

    Despite over 40 years of intense research efforts no effective treatment for AD exists, causing many scientists to question the suitability of research models used and cast doubt on the Amyloid Hypothesis.

  • Culturing Microglia? Which collagen you use could impact cell morphology

    We compared Jellagen’s Collagen Type 0 product with other collagens and laminin as a matrix for the culture of human iPSC-derived microglia 
  • Make the Switch to Mature Human Sensory Neurons - In 3 Weeks

    Millions of people around the world suffer from debilitating pain. However impressive advances are being made in neural stem cell R&D to advance pain research and drug discovery efforts. Robust, translational assays using human iPSC-derived Sensory Neurons enable researchers to delve deeper into the molecular pathways underpinning pain, to ultimately improve both the screening of drug candidates and the quality of life for people across the world.

  • Bioengineering the Human Neuromuscular Junction (NMJ)

    Loughborough University scientists use Axol motor neurons to bioengineer a 3D human model of the neuromuscular junction (NMJ), opening the door to translational assays for use in drug development for motor neuron disease.